Skip to content

Amyotrophic Lateral Sclerosis Type 5 C1865864

Published: July 22, 2026Updated: August 20, 2026

ALS Type 5 is a rare genetic form of motor neuron disease where nerve cells progressively break down. It typically affects adults and leads to muscle weakness, with treatment focused on managing symptoms and supporting function.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G12.21
ICD-11
8A00.0
Body system
neurologic
Severity
fatal
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Generalized symptoms

Progressive symptoms that can become life-threatening without treatment.

Seek immediate medical attention if symptoms worsen.

Progressive muscle weakness

(neurologic)

Fasciculations (muscle twitching)

(neurologic)

Spasticity (muscle stiffness)

(neurologic)

Respiratory insufficiency

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Disease-modifying therapy

Riluzole remains first-line disease-modifying treatment, with edaravone as an additional option in appropriate patients. Combination approaches are under investigation in clinical trials.

medication
2

Outpatient procedure with monitoring

Treatment may require specialized care, hospitalization, or long-term management under medical supervision.

procedure
3

Experimental clinical trial participation

Enrollment in clinical trials offers access to investigational therapies including gene therapies, stem cell approaches, and novel neuroprotective compounds not yet FDA-approved.

complementary

Additional treatment options

Speech and communication intervention

Early speech therapy with provision of augmentative and alternative communication devices. Voice banking preserves speech for future use with synthetic voice technology.

procedure

Diaphragm pacing evaluation

Surgical placement of diaphragm pacing system in appropriately selected patients may support respiratory function. Patient selection criteria include specific patterns of respiratory involvement.

surgical

Adaptive exercise and activity program

Water-based exercise, yoga, and tai chi adapted for ALS maintain flexibility and well-being. Focus shifts from building strength to preserving function and managing fatigue.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is Amyotrophic Lateral Sclerosis Type 5 C1865864?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Andersen PM, Abrahams S, Borasio GD. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis. Eur J Neurol. 2012.

guideline2012
2

Ajroud-Driss S, Siddique T. Sporadic and hereditary amyotrophic lateral sclerosis. Biochim Biophys Acta. 2014.

review2014
3

Benatar M, Wuu J, Andersen PM. Randomized trial of SMA11B for disease progression in amyotrophic lateral sclerosis. Neurology. 2018.

clinical_trial2018
4

Taylor JP, Brown RH Jr, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016.

meta_analysis2016

Medication Comparisons

Compare medications used to treat Amyotrophic Lateral Sclerosis Type 5 C1865864. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy